Education
About Us
Working with TipRanks
Follow Us
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
Total Valuation
Sun Pharma Advanced Research Co. Ltd. has a market cap or net worth of ₹50.76B. The enterprise value is ₹51.21B.
Market Cap₹50.76B
Enterprise Value₹51.21B
Share Statistics
Sun Pharma Advanced Research Co. Ltd. has 324,521,580 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding324,521,580
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sun Pharma Advanced Research Co. Ltd.’s return on equity (ROE) is 1.58 and return on invested capital (ROIC) is -225.68%.
Return on Equity (ROE)1.58
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-225.68%
Return on Capital Employed (ROCE)7.18
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.21
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sun Pharma Advanced Research Co. Ltd. is -13.87. Sun Pharma Advanced Research Co. Ltd.’s PEG ratio is -19.70.
PE Ratio-13.87
PS Ratio0.00
PB Ratio9.96
Price to Fair Value-21.89
Price to FCF-60.42
Price to Operating Cash Flow-73.87
PEG Ratio-19.70
Income Statement
In the last 12 months, Sun Pharma Advanced Research Co. Ltd. had revenue of 717.70M and earned -3.43B in profits. Earnings per share was -10.55.
Revenue717.70M
Gross Profit486.50M
Operating Income-2.78B
Pretax Income-3.43B
Net Income-3.43B
EBITDA-3.23B
Earnings Per Share (EPS)-10.55
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Sun Pharma Advanced Research Co. Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.56
52-Week Price Change-35.00%
50-Day Moving Average157.07
200-Day Moving Average180.81
Relative Strength Index (RSI)48.80
Average Volume (3m)173.00K
Important Dates
Sun Pharma Advanced Research Co. Ltd. upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 19, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend Date―
Financial Position
Sun Pharma Advanced Research Co. Ltd. as a current ratio of 0.07, with Debt / Equity ratio of 3.06%
Current Ratio0.07
Quick Ratio0.07
Debt to Market Cap0.05
Net Debt to EBITDA-0.83
Interest Coverage Ratio-30.75
Taxes
In the past 12 months, Sun Pharma Advanced Research Co. Ltd. has paid 2.70M in taxes.
Income Tax2.70M
Effective Tax Rate>-0.01
Enterprise Valuation
Sun Pharma Advanced Research Co. Ltd. EV to EBITDA ratio is -15.52, with an EV/FCF ratio of -13.53.
EV to Sales69.89
EV to EBITDA-15.52
EV to Free Cash Flow-13.53
EV to Operating Cash Flow-13.92
Balance Sheet
Sun Pharma Advanced Research Co. Ltd. has ₹19.60M in cash and marketable securities with ₹2.69B in debt, giving a net cash position of ₹2.67B billion.
Cash & Marketable Securities₹19.60M
Total Debt₹2.69B
Net Cash₹2.67B
Net Cash Per Share₹8.23
Tangible Book Value Per Share-₹8.34
Margins
Gross margin is 25.65%, with operating margin of -387.32%, and net profit margin of -477.23%.
Gross Margin25.65%
Operating Margin-387.32%
Pretax Margin-477.61%
Net Profit Margin-477.23%
EBITDA Margin-450.24%
EBIT Margin-467.51%
Analyst Forecast
The average price target for Sun Pharma Advanced Research Co. Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―